SHIRE VIROPHARMA LLC – Trademark Portfolio

Entity Type: 16

SHIRE VIROPHARMA LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ESOPHACREW. The owner is based in Lexington, MA.

300 Shire Way

Lexington, MA 02421

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SHIRE VIROPHARMA LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does SHIRE VIROPHARMA LLC have?

SHIRE VIROPHARMA LLC has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 7 abandoned, 2 cancelled.

What trademark classes does SHIRE VIROPHARMA LLC file in?

SHIRE VIROPHARMA LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SHIRE VIROPHARMA LLC's most well-known trademarks?

SHIRE VIROPHARMA LLC's registered trademark portfolio includes well-known marks such as ESOPHACREW. These are among 2 currently registered trademarks in the portfolio.

What is SHIRE VIROPHARMA LLC's trademark registration success rate?

SHIRE VIROPHARMA LLC has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.